Adial Pharmaceuticals, Inc. - Common Stock (ADIL)

CUSIP: 00688A205

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock
Shares outstanding
5,493,768
Total 13F shares
194,053
Share change
-89,608
Total reported value
$193,859
Price per share
$1.00
Number of holders
11
Value change
-$98,515
Number of buys
4
Number of sells
6

Security key

00688A205

Report period

Q3 2024

Institutions

11

Top holders

10

Ownership snapshot

Top shareholders of ADIL - Adial Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
UBS Group AG
13D/G signal
Evidence rows
16
Latest as of
30 Jun 2024
13F 3/4/5 Lead comparable stake: 1.5% Showing first 8 of 16 holder rows. Open remaining rows
Holder Evidence Ownership % Position 12M Net Δ As of
UBS Group AG
13F
Company
13F
1.5%
$96,146
83,605 shares
30 Jun 2024
Manchester Capital Management LLC
13F
Company
13F
0.88%
$55,312
48,097 shares
30 Jun 2024
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
0.63%
$39,498
34,346 shares
30 Jun 2024
HRT FINANCIAL LP
13F
Company
13F
0.53%
$33,000
29,228 shares
30 Jun 2024
BlackRock Finance, Inc.
13F
Company
13F
0.51%
$31,935
27,770 shares
30 Jun 2024
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
0.47%
$29,754
25,874 shares
30 Jun 2024
CITADEL ADVISORS LLC
13F
Company
13F
0.45%
$28,458
24,746 shares
30 Jun 2024
Tower Research Capital LLC (TRC)
13F
Company
13F
0.1%
$6,477
5,632 shares
30 Jun 2024
Show 8 additional holder rows in the full holder list
Holder Evidence Ownership % Position 12M Net Δ As of
1620 INVESTMENT ADVISORS, INC.
13F
Company
13F
0.07%
$4,140
3,600 shares
30 Jun 2024
BANK OF AMERICA CORP /DE/
13F
Company
13F
0.01%
$792
689 shares
30 Jun 2024
MORGAN STANLEY
13F
Company
13F
0%
$45
39 shares
30 Jun 2024
Abound Wealth Management
13F
Company
13F
0%
$32
27 shares
30 Jun 2024
Qube Research & Technologies Ltd
13F
Company
13F
0%
$10
8 shares
30 Jun 2024
William B. Stilley III
3/4/5
Director
mixed-class rows
$530,200
1,311,779 shares
mixed-class rows
23 May 2023
Joseph Truluck
3/4/5
Chief Financial Officer
mixed-class rows
$111,411
290,139 shares
mixed-class rows
25 Mar 2024
Dr. Bankole Johnson
3/4/5
Director
class O/S missing
40,000 shares
23 May 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
11
Shares
194,053
Rows loaded
11
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
13
Q3 2024 holders
11
Holder diff
-2
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .